Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
| Status: | Withdrawn |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | June 2014 |
The purpose of this study is to investigate the effect of the ReBuilder in the treatment of
individuals with breast cancer and chemotherapy induced peripheral neuropathy.
individuals with breast cancer and chemotherapy induced peripheral neuropathy.
Inclusion Criteria:
- Patients with breast cancer referred to Physical Therapy for CIPN
- Physical Therapy Examination indicates use of Rebuilder for CIPN
- At least 18 years of age
- Signed informed consent for study population
- Willingness to complete study according to protocol
Exclusion Criteria:
- Patients who do not have CIPN
- Patients <18 years of age
- Inability to or unwilling to sign informed consent
- Unable to read and understand the English language
- Preexisting sensory peripheral neuropathy from other comorbid conditions such as
diabetes or alcoholism
- More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days,
for sensory peripheral neuropathy
We found this trial at
1
site
Click here to add this to my saved trials
